Jordan, Jens
Biaggioni, Italo
Kotsis, Vasilios
Nilsson, Peter
Grassi, Guido
Fedorowski, Artur
Kario, Kazuomi
Article History
Received: 11 September 2022
Accepted: 13 September 2022
First Online: 22 November 2022
Compliance with ethical standards
:
: JJ served as an advisor for Novo-Nordisk and Bayer, received research support from Boehringer Ingelheim and Novo-Nordisk, and is co-founder of Eternygen GmbH. He is the Editor-in-Chief of <i>Clinical Autonomic Research</i> and International Associate Editor of <i>Hypertension Research</i> but was not involved in the editorial handling of this manuscript. IB is a consultant for Theravance Biopharma, Takeda Inc., and Amneal Pharmaceuticals, and has a patent for an automated abdominal binder to treat orthostatic hypotension. He is supported by NIH grants R01HL149386 and R01HL161095. VK, PN, GG, and AF report no conflicts of interest. KK is the Editor-in-Chief of <i>Hypertension Research</i> but was not involved in the editorial handling of this manuscript.